Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle

SummaryThe International Osteoporosis Foundation (IOF) Capture the Fracture Campaign aims to support implementation of Fracture Liaison Services (FLS) throughout the world.IntroductionFLS have been shown to close the ubiquitous secondary fracture prevention care gap, ensuring that fragility fracture sufferers receive appropriate assessment and intervention to reduce future fracture risk.MethodsCapture the Fracture has developed internationally endorsed standards for best practice, will facilitate change at the national level to drive adoption of FLS and increase awareness of the challenges and opportunities presented by secondary fracture prevention to key stakeholders. The Best Practice Framework (BPF) sets an international benchmark for FLS, which defines essential and aspirational elements of service delivery.ResultsThe BPF has been reviewed by leading experts from many countries and subject to beta-testing to ensure that it is internationally relevant and fit-for-purpose. The BPF will also serve as a measurement tool for IOF to award ‘Capture the Fracture Best Practice Recognition’ to celebrate successful FLS worldwide and drive service development in areas of unmet need. The Capture the Fracture website will provide a suite of resources related to FLS and secondary fracture prevention, which will be updated as new materials become available. A mentoring programme will enable those in the early stages of development of FLS to learn from colleagues elsewhere that have achieved Best Practice Recognition. A grant programme is in development to aid clinical systems which require financial assistance to establish FLS in their localities.ConclusionNearly half a billion people will reach retirement age during the next 20 years. IOF has developed Capture the Fracture because this is the single most important thing that can be done to directly improve patient care, of both women and men, and reduce the spiralling fracture-related care costs worldwide.

[1]  B. Clarke,et al.  Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Randomized Trial , 2008 .

[2]  Sei J. Lee,et al.  Missed Opportunities for Osteoporosis Treatment in Patients Hospitalized for Hip Fracture , 2010, Journal of the American Geriatrics Society.

[3]  E. Ollagnier,et al.  Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment , 2011, Osteoporosis International.

[4]  M. Cooper,et al.  Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study , 2011, Osteoporosis International.

[5]  J. Eisman,et al.  Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis , 2013, Osteoporosis International.

[6]  K. Akesson,et al.  3‐year follow‐up of 215 fracture patients from a prospective and consecutive osteoporosis screening program , 2008, Acta orthopaedica.

[7]  R. Dell,et al.  Osteoporosis disease management: What every orthopaedic surgeon should know. , 2009, The Journal of bone and joint surgery. American volume.

[8]  B. Edwards,et al.  Prior Fractures are Common in Patients with Subsequent Hip Fractures , 2007, Clinical orthopaedics and related research.

[9]  S. Sen,et al.  Undertreatment with anti-osteoporotic drugs after hospitalization for fracture , 2004, Osteoporosis International.

[10]  S. Cummings,et al.  Epidemiology and outcomes of osteoporotic fractures , 2002, The Lancet.

[11]  C. Cooper,et al.  Osteoporosis: burden, health care provision and opportunities in the EU , 2011, Archives of osteoporosis.

[12]  O Johnell,et al.  A meta-analysis of previous fracture and subsequent fracture risk. , 2004, Bone.

[13]  T. Abbott,et al.  Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  P. Hoffmeyer,et al.  An Osteoporosis Clinical Pathway for the Medical Management of Patients with Low-Trauma Fracture , 2002, Osteoporosis International.

[15]  R. Cumming,et al.  Osteoporotic fracture: missed opportunity for intervention , 2003, Osteoporosis International.

[16]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[17]  J. Kanis.  A GLOBAL CAMPAIGN TO BREAK THE FRAGILITY FRACTURE CYCLE , 2012 .

[18]  L. Lix,et al.  A population-based analysis of the post-fracture care gap 1996–2008: the situation is not improving , 2012, Osteoporosis International.

[19]  P Geusens,et al.  Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. , 2001, The New England journal of medicine.

[20]  J. A. Kanis,et al.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women , 2013, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.

[21]  G. Wood,et al.  Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years , 2003, Osteoporosis International.

[22]  C. Cooper,et al.  Epidemiology of fractures in England and Wales. , 2001, Bone.

[23]  Beate Sander,et al.  A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. , 2008, The Journal of bone and joint surgery. American volume.

[24]  R. Dell,et al.  Outcomes of an osteoporosis disease‐management program managed by nurse practitioners , 2010, Journal of the American Academy of Nurse Practitioners.

[25]  P. Geusens,et al.  Impact of guideline implementation by a fracture nurse on subsequent fractures and mortality in patients presenting with non-vertebral fractures. , 2011, Injury.

[26]  S. Boonen,et al.  Coordinator-based systems for secondary prevention in fragility fracture patients , 2011, Osteoporosis International.

[27]  Jacques P. Brown,et al.  Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis , 2004, Current medical research and opinion.

[28]  I. Pillay,et al.  Fracture liaison service in a non-regional orthopaedic clinic--a cost-effective service. , 2012, Irish medical journal.

[29]  J. Reginster,et al.  Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. , 2008, The Journal of rheumatology.

[30]  L. Z. Cosin,et al.  British Geriatrics Society , 1961 .

[31]  S. Boonen,et al.  Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data , 2012, Osteoporosis International.

[32]  P. Geusens,et al.  The fracture and osteoporosis outpatient clinic: an effective strategy for improving implementation of an osteoporosis guideline. , 2007, Journal of evaluation in clinical practice.

[33]  L. Jeys,et al.  Are osteoporotic fractures being adequately investigated?: A questionnaire of GP & orthopaedic surgeons , 2006, BMC family practice.

[34]  The Risk of a Second Hip Fracture in Patients after Their First Hip Fracture , 2011, Calcified Tissue International.

[35]  R. Goodman,et al.  The effect of risedronate on the risk of hip fracture in elderly women. , 2001, The New England journal of medicine.

[36]  M. Anthony,et al.  Sex- and age-specific incidence of non-traumatic fractures in selected industrialized countries , 2012, Archives of Osteoporosis.

[37]  N. Suhm,et al.  Management of fragility fractures in Switzerland: results of a nationwide survey. , 2008, Swiss medical weekly.

[38]  J. Oh,et al.  Patients with wrist fractures are less likely to be evaluated and managed for osteoporosis. , 2009, The Journal of bone and joint surgery. American volume.

[39]  F. McAlister,et al.  Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study , 2010, Osteoporosis International.

[40]  Claus Christiansen,et al.  Denosumab for prevention of fractures in postmenopausal women with osteoporosis. , 2009, The New England journal of medicine.

[41]  S. Majumdar,et al.  Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial. , 2007, Archives of internal medicine.

[42]  D. Beaton,et al.  Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review , 2004, Osteoporosis International.

[43]  M. Eccles,et al.  A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis , 2010, Implementation science : IS.

[44]  S. Gallacher,et al.  The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture , 2003, Osteoporosis International.

[45]  M. Seibel,et al.  Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study , 2011, Osteoporosis International.

[46]  G. Clunie,et al.  Implementing and running a fracture liaison service: An integrated clinical service providing a comprehensive bone health assessment at the point of fracture management , 2008 .

[47]  H. Teede,et al.  Fracture prevention strategies in patients presenting to Australian hospitals with minimal‐trauma fractures: a major treatment gap , 2007, Internal medicine journal.

[48]  J. Harrington,et al.  Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project. , 2005, Arthritis and rheumatism.

[49]  V. Parker,et al.  A team approach: implementing a model of care for preventing osteoporosis related fractures , 2011, Osteoporosis International.

[50]  P. Royle,et al.  Denosumab for the prevention of osteoporotic fractures in postmenopausal women. , 2011, Health technology assessment.

[51]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[52]  C. Cooper,et al.  Osteoporosis in the European Union: medical management, epidemiology and economic burden , 2013, Archives of Osteoporosis.

[53]  O. Johnell,et al.  Requirements for DXA for the management of osteoporosis in Europe , 2005, Osteoporosis International.

[54]  S. Beard,et al.  Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision , 2011, Osteoporosis International.

[55]  B. Edwards,et al.  An osteoporosis and fracture intervention program increases the diagnosis and treatment for osteoporosis for patients with minimal trauma fractures. , 2005, Joint Commission journal on quality and patient safety.

[56]  J. Kanis,et al.  Epidemiology of fracture in the Russian Federation and the development of a FRAX model , 2012, Archives of Osteoporosis.

[57]  C. Bennett,et al.  First Fracture Project: addressing the osteoporosis care gap , 2007, Internal medicine journal.

[58]  A. R. Jones,et al.  British Orthopaedic Association , 1958 .

[59]  S. Shortell,et al.  Crossing the quality chasm: implications for health services administration education. , 2004, The Journal of health administration education.

[60]  R. Parker,et al.  Low rates of treatment in postmenopausal women with a history of low trauma fractures: results of audit in a Fracture Liaison Service. , 2010, QJM : monthly journal of the Association of Physicians.

[61]  D. Beaton,et al.  Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. , 2006, The Journal of bone and joint surgery. American volume.

[62]  O. Johnell,et al.  An estimate of the worldwide prevalence and disability associated with osteoporotic fractures , 2006, Osteoporosis International.

[63]  M. van der Elst,et al.  Implementation of osteoporosis guidelines: a survey of five large fracture liaison services in the Netherlands , 2010, Osteoporosis International.

[64]  N. Walsh.  The Bone and Joint Decade. , 1998, Archives of physical medicine and rehabilitation.

[65]  R. Rizzoli.  Two‐Year Results of Once‐Weekly Administration of Alendronate 70 mg for the Treatment of Postmenopausal Osteoporosis , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[66]  J. Eisman,et al.  Successful direct intervention for osteoporosis in patients with minimal trauma fractures , 2007, Osteoporosis International.

[67]  M. Drezner,et al.  Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study , 2005, Annals of the rheumatic diseases.

[68]  S. Silverman,et al.  Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[69]  C. Inderjeeth,et al.  A multimodal intervention to improve fragility fracture management in patients presenting to emergency departments , 2010, The Medical journal of Australia.

[70]  Lauren A Beaupre,et al.  Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial. , 2009, Archives of internal medicine.

[71]  F. Piette,et al.  [Epidemiology of fractures of the proximal femur]. , 1992, Presse medicale.

[72]  D. Marsh,et al.  Osteoporosis fracture liaison experience: the Belfast experience , 2005, Rheumatology International.

[73]  D. Beaton,et al.  A program with a dedicated coordinator improved chart documentation of osteoporosis after fragility fracture , 2007, Osteoporosis International.

[74]  B. Riggs,et al.  Epidemiology of fractures of the proximal femur in Rochester, Minnesota. , 1980, Clinical orthopaedics and related research.

[75]  A. LaCroix,et al.  Predictors of Treatment with Osteoporosis Medications After Recent Fragility Fractures in a Multinational Cohort of Postmenopausal Women , 2012, Journal of the American Geriatrics Society.

[76]  E. Schoon,et al.  The fracture and osteoporosis clinic: 1-year results and 3-month compliance. , 2007, Bone.

[77]  K. Thorngren,et al.  Screening for osteoporosis reduced new fracture incidence by almost half , 2012, Acta orthopaedica.

[78]  J. Reginster,et al.  Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. , 2005, The Journal of clinical endocrinology and metabolism.

[79]  A. Scillitani,et al.  Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian survey , 2005, Osteoporosis International.

[80]  D. Beaton,et al.  Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients , 2011, Osteoporosis International.

[81]  F. Callachand,et al.  An evaluation of an enhanced fracture liaison service as the optimal model for secondary prevention of osteoporosis , 2011, JRSM short reports.

[82]  H. Trampisch,et al.  Die stationäre Behandlungsqualität der distalen Radiusfraktur in Deutschland , 2008, Der Unfallchirurg.

[83]  G. Ioannidis,et al.  The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study , 2008, Osteoporosis International.

[84]  J. H. Hegeman,et al.  Follow-up for osteoporosis in older patients three years after a fracture. , 2007, The Netherlands journal of medicine.

[85]  R. Dell,et al.  Osteoporosis disease management: the role of the orthopaedic surgeon. , 2008, The Journal of bone and joint surgery. American volume.

[86]  S. Berney,et al.  Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis , 2008 .

[87]  Steven Boonen,et al.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. , 2007, The New England journal of medicine.

[88]  C. Cooper,et al.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women , 2008, Osteoporosis International.

[89]  S. Cummings,et al.  Rapidly increasing rates of hip fracture in Beijing, China , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[90]  F. Bonnaire,et al.  [Quality of care after distal radius fracture in Germany. Results of a fracture register of 1,201 elderly patients]. , 2009, Der Unfallchirurg.

[91]  L. Munuera,et al.  Interventions to improve inpatient osteoporosis management following first osteoporotic fracture: the PREVENT project , 2009, Archives of Orthopaedic and Trauma Surgery.